Showing results (361-370 of 1,319) with videos related to
Sort By:
Pageof 132
Cardiovascular Toxicology|December 20, 2016
Doxorubicin and Liposomal Doxorubicin Differentially Affect Expression of miR-208a and let-7g in Rat Ventricles and AtriaJan Novak, Jiri Sana, Tibor Stracina, et al.Cardiovascular Toxicology|March 12, 2017
Association of Fasting Serum Bilirubin Levels with Clinical Outcomes After Percutaneous Coronary Intervention: A Prospective StudyMing-Ming Zhang, Ying Gao, Ying-Ying Zheng, et al.Cardiovascular Toxicology|February 22, 2017
Lipopolysaccharide Activates Toll-Like Receptor 4 and Prevents Cardiac Fibroblast-to-Myofibroblast DifferentiationSamir Bolívar, Roxana Santana, Pedro Ayala, et al.Cardiovascular Toxicology|May 10, 2014
The correlation between prolonged corrected QT interval with the frequency of respiratory arrest, endotracheal intubation, and mortality in acute methadone overdoseDavood Farsi, Amirhossein Mirafzal, Hossein Hassanian-Moghaddam, et al.Cardiovascular Toxicology|October 27, 2016
Cardiotoxicity Associated with Nicotinamide Phosphoribosyltransferase Inhibitors in Rodents and in Rat and Human-Derived Cells LinesD L Misner, M A Kauss, J Singh, et al.Cardiovascular Toxicology|February 11, 2017
Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and DomperidoneGerrit Frommeyer, Christina Fischer, Christian Ellermann, et al.Cardiovascular Toxicology|October 14, 2003
Apoptosis in heart failure and the senescent heartOliver Y Bernecker, Fawzia Huq, E Kevin Heist, et al.Cardiovascular Toxicology|October 14, 2003
Therapeutic angiogenesis: a complex problem requiring a sophisticated approachKeith A WebsterCardiovascular Toxicology|March 23, 2004
Carvedilol inhibits the mitochondrial permeability transition by an antioxidant mechanismPaulo J Oliveira, Telma Esteves, Anabela P Rolo, et al.Cardiovascular Toxicology|March 23, 2004
Inhibition of cardiac myocyte contraction by 4-hydroxy-trans-2-nonenalNicholas S Aberle, Matthew J Picklo, Venkataraman Amarnath, et al.Pageof 132